Skip to content
drillr.ai
Sign up

PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

NASDAQ · Healthcare · Medical - Devices · US

$1.84
+6.36%
Ask drillr

  • Oct 19, 2026, 13:05 UTC

    PACIFIC BIOSCIENCES OF CALIFORNIA, INC. and Verily Life Sciences LLC announced a multi-year collaboration to connect PACIFIC BIOSCIENCES OF CALIFORNIA, INC. HiFi Sequencing with Verily Pre’s governed cloud analysis, multimodal health data and AI-ready research workflows.

    Source:

  • Oct 14, 2026, 23:16 UTC

    PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shares closed at $1.99, down 2.93% from the previous trading day.

    Source:

  • Oct 8, 2026, 23:16 UTC

    PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shares fell 15.44% to $2.30 from the previous close.

    Source:

  • Oct 6, 2026, 13:05 UTC

    PacBio and TychoBio announced a collaboration in which PacBio's Kinnex sequencing will generate full-length transcript data to advance TychoBio's AI drug discovery models for rare disease RNA therapeutics.

    Source:

  • Sep 25, 2026, 23:15 UTC

    Pacific Biosciences of California (PACB) shares closed at $1.62, up 2.53% from the previous day's close.

    Source:

  • Sep 17, 2026, 23:15 UTC

    Pacific Biosciences of California (PACB) shares closed at $1.38, up 2.99% from the previous trading session.

    Source:

  • Sep 2, 2026, 18:56 UTC

    PacBio cut its 2026 revenue outlook due to weaker instrument demand and a slower SPRQ-Nx transition.

    Source:

  • Aug 16, 2026, 07:02 UTC

    Pacific Biosciences of California cut its outlook due to slower SPRQ-N transition and targeted cash-flow positivity by 2028.

    Source:

  • Aug 6, 2026, 04:04 UTC

    Pacific Biosciences of California announced an immediate leadership transition.

    Source:

  • Aug 5, 2026, 20:05 UTC

    PacBio announced its financial results for the quarter ended June 30, 2026, on August 5, 2026.

    Source:

  • Jun 4, 2026, 00:00 UTC

    Pacific Biosciences of California elected William Ericson, Kathy Ordoñez, Christopher M. Smith, Chris Gibson, and Christian O. Henry as Class III directors, effective June 3, 2026.

  • Jun 1, 2026, 16:11 UTC

    PacBio (PACB) launched the commercial availability of SPRQ-Nx technology for its Revio sequencing system, which lowers sequencing costs by about 30% and adds AI and epigenetics upgrades.

    Source: